Patient moving all four extremities, disoriented prior to intubation in ED.
100 GEN: awake, combative, disoriented, does not follow command HEENT: PERLA, sluggish, 3mm bilateral, collar, no deformity CARDIO: S1S2, RRR PULM: CTAB [**Last Name (un) **]: soft, NT/ND EXTR: moves extr symmetrically NEURO: DTR brisk, toes downgoing  Pertinent Results: [**2192-2-12**] 01:10AM   WBC-19.5* RBC-4.97 HGB-14.9 HCT-41.3 MCV-83 MCH-30.0 MCHC-36.1* RDW-12.4 [**2192-2-12**] 01:10AM   PLT COUNT-306 [**2192-2-12**] 01:10AM   PT-13.7* PTT-28.1 INR(PT)-1.2 [**2192-2-12**] 01:10AM   GLUCOSE-139* UREA N-14 CREAT-0.8 SODIUM-133 POTASSIUM-4.2 CHLORIDE-99 TOTAL CO2-19* ANION GAP-19 [**2192-2-12**] 01:10AM   ALT(SGPT)-31 AST(SGOT)-142* ALK PHOS-57 AMYLASE-61 TOT BILI-1.3 [**2192-2-12**] 01:10AM   LIPASE-17 [**2192-2-12**] 01:10AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2192-2-12**] 01:10AM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG [**2192-2-12**] 01:10AM URINE  BLOOD-LG NITRITE-NEG PROTEIN-500 GLUCOSE-100 KETONE-150 BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-TR [**2192-2-12**] 01:10AM URINE  RBC->50 WBC-[**5-25**]* BACTERIA-MOD YEAST-NONE EPI-[**2-18**] [**2192-2-12**] 04:07PM CEREBROSPINAL FLUID (CSF)  PROTEIN-309* GLUCOSE-57 [**2192-2-12**] 04:07PM CEREBROSPINAL FLUID (CSF)  WBC-100 RBC-[**Numeric Identifier **]* POLYS-81 LYMPHS-12 MONOS-7 [**2192-2-12**] 04:07PM CEREBROSPINAL FLUID (CSF)  WBC-44 RBC-[**Numeric Identifier 43206**]* POLYS-77 LYMPHS-17 MONOS-6 ## CT head [**2192-2-12**]: Right frontal and temporal hemorrhagic contusions , small right frontal, parafalcine subdural and subarachnoid hemorrhages, not significantly changed compared with the study of eleven (11) hours prior.
Brief Hospital Course: Ms. [**Known lastname 60146**] was admitted to the TSICU intubated and sedated in stable condition.
She continued to receive antibiotics until her her CSF gram stain, culture, HSV, RPR, bacterial antigens returned negative.
She was continued on her home buprenorphine at 2mg [**Hospital1 **] and was given haldol as needed for agitation.
She also received dilantin for seizure prophylaxis.
This was believed to be part due to her intracranial hemorrhage, her underlying psychiatric disorders, and her drug addiction therapy.
She was closely followed by psychiatry and recommendations were made to discontinue the ativan and maintain haldol as needed for agitation, place the patient in a veil bed, and add seroquel and trazodone to her regimen.
This was well tolerated by the patient and her restraints were subsequently removed.
The sitter was removed after a day of observation and the patient did well and was compliant without supervision.
Buprenorphine 2 mg twice daily  Discharge Medications: 1.
Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Buprenorphine HCl 8 mg Tablet, Sublingual Sig: Two (2) mg Sublingual [**Hospital1 **] (2 times a day).
you remained stable throughout your stay and were given medications to prevent further damage to your brain.
please continue to take your medications as prescribed.
